Dr. Marcello Di Giammarco | Carcinoma | Best Researcher Award

Posted on by Pencis

Dr. Marcello Di Giammarco | Carcinoma | Best Researcher Award

University of Pisa & Institute for Informatics and Telematics (IIT-CNR) | Italy

Author Profile

Scopus

Google Scholar

🧑‍🔬 Marcello Di Giammarco: Ph.D. Student in Biomedical Engineering

🎓 Education

Master in Biomedical Engineering
Università degli Studi 'Roma Tre', Rome, Italy
📜 Degree: 2nd level degree in Biomedical Engineering
📈 Final Mark: 104/110
📚 Thesis: EEG Signal Processing Functional to the Description of Cortical Network in Patients with Acute Ischemic Stroke
📅 2018 - 2020

Bachelor in Electronic Engineering
Università degli Studi 'Roma Tre', Rome, Italy
📜 Degree: 1st level degree in Information Technology
📈 Final Mark: 88/110
📚 Thesis: BCI - Brain Computer Interface for Communication and Rehabilitation
📅 2012 - 2017

💼 Work Experience

Ph.D. Student in Information Engineering
Università di Pisa, Pisa, Italy
📅 11/2022 - Present

📚Responsibilities:

  • Research project 'Artificial Intelligence and Cybersecurity in Medical Sector'
  • Conducting doctoral courses and seminars
  • Co-supervisor for Medical Engineering students
  • Research activities, testing artificial networks for medical purposes
  • Publishing articles and presenting at conferences
  • PC member in KES 2024 and EIAB 2024
  • Final doctoral thesis: Personal research project

🌟Co-relator

Università degli Studi del Molise, CB, Italy
📅 02/2022 - Present

📜Responsibilities:

  • Co-supervisor for Medical Engineering students
  • Number of students supervised: 7
  • Skills acquired: Presenting topics to students, using platforms for remote interaction

🌐 Language Skills

Italian

  • Mother Tongue

English

  • Listening: C1
  • Reading: C1
  • Writing: C1
  • Spoken Interaction: C1
  • Spoken Production: C1

💻 Digital Competences

  • Information and Data Literacy: Independent user
  • Communication and Collaboration: Independent user
  • Digital Content Creation: Basic user
  • Safety: Basic user
  • Problem-Solving: Independent user

🌍Office Automation:

  • Office Suite: Advanced
  • Presentation Software: Advanced
  • Spreadsheets: Intermediate
  • Web Browser: Intermediate
  • Word Processors: Advanced

📱Computer Programming:

  • LaTeX: Intermediate
  • C++: Advanced
  • MATLAB: Advanced
  • Python: Intermediate

🔬Systems and Networks Management:

  • Network Architecture: Advanced
  • Operating Systems: Highly Specialized
  • Linux: Intermediate

🚗 Driving Licence

  • Category B

🏅 Additional Certifications

  • Corso Art.37: Lupi Estintori SRL, 2020-10-25
  • Corso di Primo Soccorso: Lupi Estintori SRL, 2020

🎓 Relevant Courses

  • English for Research Publication and Presentation Purposes: University of Pisa, 2023 (C1 Level)

 

📊🔬Notable Publication:

 

  • Diabetic Retinopathy Detection and Diagnosis by Means of Robust and Explainable Convolutional Neural Networks
    • Authors: Mercaldo, F., Di Giammarco, M., Apicella, A., Martinelli, F., Santone, A.
    • Journal: Neural Computing and Applications
    • Year: 2023

 

  • Explainable Deep Learning for Alzheimer Disease Classification and Localisation
    • Authors: Di Giammarco, M., Iadarola, G., Martinelli, F., Ravelli, F., Santone, A.
    • Journal: Communications in Computer and Information Science
    • Year: 2022

 

  • High Grade Brain Cancer Segmentation by Means of Deep Learning
    • Authors: Di Giammarco, M., Martinelli, F., Mercaldo, F., Santone, A.
    • Journal: Procedia Computer Science
    • Year: 2022

 

  • Deep Learning for Heartbeat Phonocardiogram Signals Explainable Classification
    • Authors: Cesarelli, M., Di Giammarco, M., Iadarola, G., Mercaldo, F., Santone, A.
    • Journal: Proceedings - IEEE 22nd International Conference on Bioinformatics and Bioengineering, BIBE 2022
    • Year: 2022

 

  • Explainable Deep Learning Methodologies for Biomedical Images Classification
    • Authors: Di Giammarco, M., Mercaldo, F., Martinelli, F., Santone, A.
    • Journal: Proceedings - International Conference on Distributed Computing Systems, 2022
    • Year: 2022

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

University of Health Sciences, Izmir | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

  • Assoc Prof Dr. Elçin Aydın’s academic journey began with a strong foundation in medical sciences. She pursued her education with a focus on radiology, demonstrating a keen interest in the diagnostic and therapeutic applications of imaging technologies. Her early academic pursuits laid the groundwork for her specialization in abdominal and genitourinary radiology.

PROFESSIONAL ENDEAVORS

  • Dr. Aydın is currently affiliated with the University of Health Sciences in Izmir, Turkey, and works at Izmir City Hospital. Her professional endeavors have been marked by a commitment to clinical excellence and academic rigor. She has been an active member of prestigious organizations such as the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Congress of Radiology (ECR), and the European Society of Urogenital Radiology (ESUR).

CONTRIBUTIONS AND RESEARCH FOCUS

  • Dr. Aydın has made significant contributions to the field of radiology through her research and clinical work. She has published 14 original articles in SCI-EXP indexed journals and authored 4 case studies, highlighting her expertise in abdominal and genitourinary radiology. Her research focuses on the diagnostic accuracy and clinical applications of imaging techniques in these areas, aiming to improve patient outcomes through advanced radiological practices.

IMPACT AND INFLUENCE

  • Through her scholarly publications and clinical practice, Dr. Aydın has had a considerable impact on the field of radiology. Her work is frequently cited by peers, reflecting the influence of her research on contemporary radiological practices. Her involvement in ESGAR, ECR, and ESUR underscores her influence within the radiological community, where she contributes to the advancement of knowledge and practice standards.

ACADEMIC CITATIONS

  • Dr. Aydın’s research has garnered significant academic attention, with numerous citations in prominent radiological journals. Her studies on abdominal and genitourinary radiology are referenced by other researchers and clinicians, indicating the high regard in which her work is held. This academic recognition is a testament to the quality and relevance of her research contributions.

LEGACY AND FUTURE CONTRIBUTIONS ON ENDOMETRIUM CANCER

  • Dr. Aydın’s legacy in the field of radiology is characterized by her dedication to advancing medical imaging and improving patient care. Looking ahead, she is poised to continue her impactful research and clinical work, with a focus on innovative imaging techniques and their applications in abdominal and genitourinary radiology. Her future contributions are expected to further enhance the understanding and practice of radiology, benefiting both the medical community and patients.

OTHER IMPORTANT TOPICS

TEACHING AND MENTORSHIP

  • In addition to her research and clinical responsibilities, Dr. Aydın is deeply committed to teaching and mentoring the next generation of radiologists. Her role at the University of Health Sciences allows her to shape the education and training of medical students and residents, ensuring the continued growth and development of the field.

COLLABORATIVE PROJECTS

  • Dr. Aydın actively engages in collaborative projects with other institutions and researchers. These collaborations enable the sharing of knowledge and expertise, fostering innovation and improving radiological practices globally. Her collaborative efforts have resulted in several joint publications and research initiatives.

PROFESSIONAL DEVELOPMENT

  • Continuous professional development is a cornerstone of Dr. Aydın’s career. She regularly participates in international conferences, workshops, and training programs to stay abreast of the latest advancements in radiology. This commitment to lifelong learning ensures that she remains at the forefront of her field, providing the highest standard of care to her patients.

 

📊🔬Notable Publication:

Extrapulmonary Tuberculosis: An Old but Resurgent Problem

  • Authors: Baykan, A.H., Sayiner, H.S., Aydin, E., Inan, I., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2022

 

Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study

  • Authors: Altunisik, E., Baykan, A.H., Sahin, S., Aydin, E., Erturk, S.M.
    Journal: American Journal of Neuroradiology
  • Year: 2021

 

Primary Breast Tuberculosis: Imaging Findings of a Rare Disease

  • Authors: Baykan, A.H., Sayiner, H.S., Inan, I., Aydin, E., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2021

 

Reliability of Real-Time Sonoelastography in the Diagnosis of Supraspinatus Tendinopathy

  • Authors: Aydın, E., Söylev, G.Ö., Muratlı, S.K., Tekindal, M.A., Ağıldere, M.
    Journal: Ultrasound Quarterly
  • Year: 2021

 

Optical Coherence Tomography-Angiography Findings of Prediabetic Patients

  • Authors: Emre, S., Altin, C., Ulusoy, M.O., Aydin, E.
    Journal: Oman Journal of Ophthalmology
  • Year: 2024

Ms. Hadil Suliman Hussein | Cancer Nanomedicine | Best Researcher Award

Posted on by Pencis

Ms. Hadil Suliman Hussein | Cancer Nanomedicine | Best Researcher Award

Pan African University |  Kenya

Author Profile

Scopus

Orcid Id

🎓 Hadil Suliman Hussein Adam: Molecular Biologist and Educator 🌱

Date of Birth: 12/09/1996
Nationality: Sudanese

Contact Information:
📞 (+249) 925387641 (Mobile)
📞 (+254) 745676806 (Mobile)
📧 Hussein.hadil@students.jkuat.ac.ke
📧 Hadeeeeel196@gmail.com

Social Media:
🌐 Facebook
🌐 LinkedIn
📱 WhatsApp: +254745676806

Addresses:
🏠 Aljarafa, Wadi St, House no 1888, 14411, Khartoum, Sudan (Home)
🏢 Juja, Icon Apartment, 00200, Nairobi, Kenya (Work)

🧬 Professional Experience

Research Assistant, Al-Neelain Stem Cell Center
10/07/2021 – Current, Khartoum, Sudan

  • Conducted research on molecular biology and stem cells, with a focus on osteoarthritis patients.
  • Designed protocols for stem cell isolation from various sources.
  • Provided assistance in the Osteoarthritis Clinic and trained students in molecular biology techniques.

Teaching Assistant, Al-Neelain University, College of Science and Technology
08/03/2021 – Current, Khartoum, Sudan

  • Prepared laboratory materials for practical sessions in zoology, histology, and stem cell techniques.
  • Taught zoology, histology, and advanced stem cell techniques to undergraduate students.
  • Assisted in grading and provided feedback to students.

🎓 Education

Master’s Degree in Molecular Biology and Biotechnology
01/04/2022 – Current, The Pan African University Institute for Basic Science, Technology and Innovation (PAUSTI), Nairobi, Kenya
Thesis: Antiproliferative and anti-metastatic activities of Catharanthus roseus-based silver nanoparticles (AgNPs) against cervical cancer

Bachelor’s Degree in Biology
20/01/2014 – 30/12/2020, Al-Neelain University, Khartoum, Sudan
Final Grade: 76.94%
Thesis: Phytochemical screening and antimicrobial activity of methanol & n-Hexane extract of roots S.Lappa

📜 Training and Certifications

  • Computer Science Training Course
    02/28/2010 – 31/05/2010, Intercontinental Institute for Computer Science, Omdurman, Sudan
  • Molecular Biology Techniques Practical Training
    05/08/2017 – 12/08/2017, National Center for Research, Khartoum, Sudan
  • Quality Control Practical Training
    02/03/2019 – 16/03/2019, Sudanese Standards and Metrology Organization, Khartoum, Sudan
  • Community-Based Health First Aid Training
    18/10/2020 – 18/11/2020, Sudanese Red Crescent, Khartoum, Sudan
  • Introduction to Bioinformatics Training (IBT)
    05/07/2021 – 05/11/2021, Pan African Bioinformatics Network For H3Africa
  • Online Courses in Cancer Biology and Management
    2020-2021, Johns Hopkins University and other institutions

🏆 Awards and Honors

  • Scientific Cultural Week – Al-Neelain University
    02/07/2018 – Second place for cancer topic in the Faculty of Science and Technology.
  • Pan Africa Scholarship
    04/2022 – Full scholarship for a master’s degree at PAUSTI.
  • 3rd Runner-Up Best Poster Presentation
    06/12/2023 – 08/12/2023, 1st Cancer Research Symposium – Poster on “Anticancer potential of silver nanoparticles biosynthesized using Catharanthus roseus leaves extract on cervical cancer.”

🔬 Publications and Research Projects

  • Phytochemical Screening and Antimicrobial Activity of Methanol and n-Hexane Roots Extract of Saussurea Lappa 30/09/2020 – 31/10/2020
  • Antiproliferative and Anti-metastatic Activities of Catharanthus roseus-based Silver Nanoparticles (AgNPs) Against Cervical Cancer 01/04/2023 – Current

🌐 Networks and Memberships

  • American Association for Cancer Research (Associate Member)
    02/08/2023 – 31/12/2023
  • Biochemistry and Biotechnology Professionals Society of Kenya (BBPSK)
    01/06/2023 – 01/06/2024
  • Young African Leaders Initiative Network (YALI)
    06/09/2021 – Current

🌍 Volunteering

Volunteer, Brothers in Humanity Initiative
24/10/2019 – Current, Khartoum, Sudan

  • Participated in blood donation campaigns and health awareness activities focused on childhood cancer.

🛠️ Digital Skills

  • Microsoft Office Suite, R Programming, SPSS, GraphPad Prism, OrginPro, Bioinformatics Software (BIOEDIT, DNAsp, TSC, GENE BANK, STRUCTURE), Molecular Docking, Linux (Terminal Commands, Bash/Shell)

🌟 Hobbies and Interests

  • Volunteering, Website Design, Teamwork, Leadership, Flexibility

📇 References

Dr. Caroline Ngugi
Senior Lecturer and Chairperson, Department of Medical Microbiology, JKUAT
📧 cwngugi@jkuat.ac.ke | 📞 (+254) 72256790

Prof. Hiba Khalil
Professor of Hematology and Stem Cell Technology, Director, Al-Neelain Stem Cell Center
📧 hibabadr@gmail.com | 📞 (+249) 123012356

Dr. Seedahmed A. Mohammed
Assistant Professor, Al-Neelain University
📧 seedahmed@neelain.edu.sd | 📞 (+249) 904030042

Dr. Faisal Koua
Scientist, FS-CFEL-1 Biomedical Research with X-Rays, Deutsches Elektronen-Synchrotron
📧 fkoua@asu.edu | 📞 (+49) 4089986372

Dr. Atif Idrees
Head of the Department of Biology and Biotechnology, Professor of Immunology, Al-Neelain University
📧 atifokaz@gmail.com | 📞 (+249) 123664711

📊🔬Notable Publication:

Title: Anticancer potential of silver nanoparticles biosynthesized using Catharanthus roseus leaves extract on cervical (HeLa229) cancer cell line

Authors: Hadil Suliman Hussein Adam, [other authors if applicable]

Journal: Scientific African

Year: 2024

Assist Prof Dr Matthias Bartneck | Cancer Therapy | Best Researcher Award

Posted on by Pencis

Assist Prof Dr Matthias Bartneck | Cancer Therapy | Best Researcher Award 

RWTH Aachen University | Germany

AUTHOR PROFILE

Scopus

Google Scholar

Orcid ID

EARLY ACADEMIC PURSUITS

Priv.-Doz. Dr. rer. nat. Matthias Bartneck embarked on his academic journey with a diploma in Biology from the University of Bielefeld (2001-2006). His diploma thesis focused on gene expression and metabolite profiling of human primary mamma carcinomas, under the supervision of Dr. Anke Becker. He continued his academic pursuits with a Doctor of Natural Sciences degree from RWTH Aachen (2007-2010), where his research centered on the interactions of human primary immune cells with various nanomaterials. This work was supervised by Prof. Gabriele Zwadlo-Klarwasser.

PROFESSIONAL ENDEAVORS

Dr. Bartneck’s professional career has been marked by a series of significant positions and collaborations. He has been employed at the Medical Faculty 10, Gastroenterology, and Faculty 1 Leibniz Institute for Interactive Materials DWI/RWTH Institute for Technical and Macromolecular Chemistry (ITMC) since 2023. He has also served as a guest lecturer at the Max Planck Research Training School Matter to Life. From 2018 to 2022, he was a lecturer at the Center for Functional Magnetic Materials, Immanuel Kant Baltic Federal University in Kaliningrad, Russia. Additionally, Dr. Bartneck has been a group leader at the Medical Faculty, Medical Clinic III, RWTH Aachen since 2014, focusing on immunomodulatory nanomedicine for inflammatory diseases and cancer.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER THERAPY

Dr. Bartneck’s research has significantly advanced the fields of gastroenterology, hepatology, and nanomedicine. His work has delved into the development of novel nanocarriers for treating liver diseases and cancer, as well as the modulation of immune cell migration and activation in inflammatory diseases. His research has been supported by substantial funding, including grants from the German Research Foundation (DFG) and the Wilhelm Sander Foundation. His contributions include over 61 publications, 18 as the first author and 4 as the last author, along with 7 book chapters and 9 reviews.

CITATIONS

  • Zitate           4439
  • h-index        35
  • i10-index     49

IMPACT AND INFLUENCE

Dr. Bartneck’s research has had a profound impact on the scientific community, evidenced by a total of 3764 citations and an H-index of 32. His expertise in immunomodulatory nanomedicine has led to collaborations with prestigious institutions and industry partners, including Bayer Healthcare, Novartis, and Precision Nanosystems. His work has been recognized with several fellowships and awards, such as the Young Investigator Award from the European Association for the Study of the Liver (EASL).

ACADEMIC CITES

Dr. Bartneck has held numerous academic positions and provided significant contributions to teaching and mentoring. He has supervised a wide range of students, from bachelor to doctoral levels, across multiple disciplines including medicine, chemistry, and biology. His teaching roles have included lectures and practical courses in materials science, blood and defense, and inflammation at RWTH Aachen.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Bartneck’s legacy is marked by his interdisciplinary approach and dedication to advancing nanomedicine and immunology. He has secured research funds exceeding €1,500,000 in 2022 alone for the development of novel lipid-based nucleic acid therapeutics. His future contributions are expected to further enhance the understanding and treatment of inflammation-associated diseases and cancer. His continued collaborations with international academic and industry partners underscore his commitment to advancing scientific knowledge and innovation.

NOTABLE PUBLICATION:

Citation: 08         Year: 2022

Citation: 01        Year: 2023

 

Prof Dr. Rommel MarioRodriguez Burbano – Oncology and Precision Medicine – Best Researcher Award

Posted on by Pencis

Prof Dr. Rommel MarioRodriguez Burbano - Oncology and Precision Medicine - Best Researcher Award

Ophir Loyola Hospital - Brazil

AUTHOR PROFILE

Google Scholar

Scopus

Orcid

EARLY ACADEMIC PURSUITS

Rommel Mario Rodríguez Burbano began his academic journey by earning a degree in Biomedicine from the Federal University of Pará in 1989. He then pursued further education, completing his Master's (1993) and Ph.D. (1998) in Biological Sciences (Genetics) from the Faculty of Medicine of Ribeirão Preto, University of São Paulo.

PROFESSIONAL ENDEAVORS

After completing his formal education, Rommel embarked on a diverse and impactful professional career. He conducted post-doctoral research in Morphology at the Discipline of Genetics, Escola Paulista de Medicina, Federal University of São Paulo in 2005. Currently, he holds the prestigious position of Full Professor at the Federal University of Pará.

CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY AND PRECISION MEDICINE

Rommel Mario Rodríguez Burbano's contributions to academia are significant and multifaceted. His research primarily focuses on Human Genetics, Cell Biology, and Oncology. Throughout his career, he has demonstrated a keen interest in understanding molecular mechanisms underlying diseases, particularly cancer.

IMPACT AND INFLUENCE

Rommel's work has had a profound impact on the scientific community. His extensive publication record, comprising 296 scientific articles in specialized journals, one book, and seven book chapters, reflects his dedication to advancing knowledge in his field.

ACADEMIC CITATIONS

Rommel's research output has garnered considerable attention, as evidenced by his numerous academic citations. His work is widely recognized and cited by peers, contributing significantly to the advancement of scientific knowledge.

LEGACY AND FUTURE CONTRIBUTIONS

As a mentor and supervisor, Rommel has played a pivotal role in shaping the next generation of scientists. He has supervised a total of 44 master's theses, 41 doctoral theses, and mentored five postdoctoral fellows. His legacy extends beyond his own research contributions, influencing the work of numerous scholars who have benefited from his guidance and expertise.

HIGHLIGHTS

Rommel currently serves as the Coordinator of the Molecular Biology Laboratory at Hospital Ophir Loyola in Belém, Pará, indicating his leadership in translational research.He holds the Process and Molecular Biomarker patent, demonstrating his innovative approach to addressing scientific challenges.Rommel's involvement in editorial boards of 12 scientific journals and his role as a reviewer for numerous scientific publications underscore his commitment to peer-reviewed research and quality scholarship.

NOTABLE PUBLICATIONS

Homocystein, Vitamin B12 and Folic Acid as Screening Biomarkers in Early Diagnosis and Gastric Cancer Monitoring.  2024

Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials. 2024

Molecular Profile of Variants Potentially Associated with Severe Forms of COVID-19 in Amazonian Indigenous Populations. 2024 (1)

Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials. 2024

PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia. 2023

 

 

Prof. Paolo De Simone – Oncology Therapy – Most Liked Article Award

Posted on by Pencis

Prof. Paolo De Simone - Oncology Therapy - Most Liked Article Award

UNIVERSITY OF PISA - Italy

Author Profile

Google Scholar
Scopus
Orcid

EARLY ACADEMIC PURSUITS

Paolo De Simone graduated summa cum laude in Medicine and Surgery from the University of Rome La Sapienza. His thesis was titled "Laparoscopic cholecystectomy in the treatment of gallstone lithiasis: prospective analysis of the results of our experience" under the supervision of Prof. Raffaello Cortesini.He earned his Specialist Diploma in General Surgery summa cum laude from the University of Rome “La Sapienza”. His thesis focused on "The role of laparoscopic surgery in the treatment of benign and malignant gastric pathologies" under the guidance of Prof. Raffaello Cortesini.Paolo De Simone achieved his PhD summa cum laude in Surgical Pathophysiology.

PROFESSIONAL ENDEAVORS

Registered in the Order of Doctors-Surgeons and Dentists of the Province of Rome with registration number 46702. He also qualified to practice the medical-surgical profession at the University of Rome “La Sapienza”. He served as a Foreign Resident-Assistant at the General Surgery Service of CHU André Vésale, Université Libre de Bruxelles, Montigny-Le-Tilleul, Belgium, and at the Thoracic and Vascular Surgery Service of the Hospital Avicenne, Bobigny, France. Paolo De Simone held several medical director positions:General Surgery Unit, Civil Hospital of Vittorio Veneto (TV),Organ Transplant Unit, San Salvatore Civil Hospital, L'Aquila,Service de Chirurgie Digestive, Hopital Erasme, Université Libre de Bruxelles, Brussels,University Liver Transplantology Unit, Pisa University Hospital.Currently, he is an Associate Professor of Surgery at the University of Pisa. He was elected Director of the School of Specialization in Surgery of the Digestive System and serves as Director of the Liver Surgery and Liver Transplant Unit, AOUP.

CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY THERAPY

Appointed as the Coordinator of the regional liver transplant program by DGRT of 17 December 2018, n. 1450. He also managed clinical, scientific, and educational coordination of terminal liver failure and liver transplantation (DG AOUP Resolution 852 of 09/20/2023).His research has covered areas like laparoscopic cholecystectomy, treatment of benign and malignant gastric pathologies, and liver transplantology.

IMPACT AND INFLUENCE

As Coordinator of the Liver Transplant Program of the Tuscany Region, he has significantly contributed to the advancement of liver transplantation in the region.

LEGACY AND FUTURE CONTRIBUTIONS

Paolo De Simone's legacy lies in his extensive contributions to the fields of general surgery, liver surgery, and liver transplantology. His future contributions are anticipated in enhancing liver transplant programs, furthering research in surgical pathophysiology, and mentoring the next generation of surgeons through his academic roles.

NOTABLE PUBLICATIONS

Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation.

First-in-human liver transplantation from a centenarian deceased donor after brain death.

Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation.

An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation.

An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients.

 

Dr. Francesco Raspagliesi – Gynecologic Oncology – Best Researcher Award

Posted on by Pencis

Dr. Francesco Raspagliesi - Gynecologic Oncology - Best Researcher Award

Fondazione IRCCS Istituto nazionale Tumori di Milano - Italy  

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Francesco Raspagliesi began his academic journey with a Degree in Medicine and Surgery from the University of Catania, Italy, which he completed on March 7, 1981. Following this foundational education, he obtained qualifications to practice medicine in 1981 and specialized in Obstetrics and Gynecology from the University of Catania in 1985 and 1988. These early academic pursuits laid the groundwork for his future professional endeavors in the field of gynecologic oncology.

PROFESSIONAL ENDEAVORS

From 1985 to 1992, Raspagliesi served as a Research Fellow at the Fondazione IRCCS Istituto Nazionale Tumori di Milano. He continued his professional growth at the same institution, becoming a Dirigente Medico di 1° Livello from 1992 to 1999 and advancing to Dirigente Medico di 2° Livello Gynecologic Oncology Unit Director from 1999 to 2019. His long-standing association with the Fondazione IRCCS Istituto Nazionale Tumori di Milano demonstrates his commitment and dedication to the field of gynecologic oncology and patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON GYNECOLOGIC ONCOLOGY

Throughout his career, Raspagliesi has made significant contributions to the field of Obstetrics and Gynecology. His research and clinical work have focused on gynecologic oncology, particularly in the treatment and management of gynecologic cancers. His expertise and leadership as the Gynecologic Oncology Unit Director have contributed to advancements in the diagnosis, treatment, and care of patients with gynecologic cancers.

IMPACT AND INFLUENCE

As a respected figure in the field of gynecologic oncology, Raspagliesi's work has had a profound impact on patient care, research, and education. His leadership roles and contributions to research have helped shape the way gynecologic cancers are treated and managed, influencing clinical practice and improving patient outcomes.

LEGACY AND FUTURE CONTRIBUTIONS

Francesco Raspagliesi's legacy in the field of Obstetrics and Gynecology is characterized by his dedication to patient care, leadership in gynecologic oncology, and contributions to research and education. His continued commitment to advancing the field through research, mentorship, and clinical practice ensures that his influence will be felt by future generations of gynecologic oncologists.

NOTABLE PUBLICATIONS

Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.  2024

Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes. 2024

Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.  2024

Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens. 2024

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics? (2) 2024